Pacific Horizon's Treasury Buyback: Buying Asian Growth at a Near-10% Discount

Every few weeks the same announcement crosses the wire: Pacific Horizon bought back another small block of its own shares and set them aside in treasury. A company repurchasing stock is routine. A fund repurchasing stock is a different animal, and the difference is where the useful signal sits.

Pacific Horizon (LSE: PHI) is a closed-end investment trust managed by Baillie Gifford, launched in 1989 to hold the fast-growing companies of Asia-Pacific and the Indian subcontinent — names like TSMC, Tencent, Samsung and Alibaba, the growth names a U.S. investor can't easily reach through a domestic index. "Closed-end" is the whole story: the trust raised a fixed pool of money, and its shares trade on the London exchange separately from the value of the assets they own. That floating gap between share price and net asset value (NAV) is the only valuation that really matters here.

Right now the gap is wide. In early September the portfolio behind each share was estimated at 1,228 pence, and the shares were being bought back at roughly 1,090–1,120 pence — a discount of close to 10%, or about eleven percent below the estimated NAV on the latest transaction.

Why that makes the buyback worth a second look: when the board pays roughly 1,093 pence to pull a share whose NAV is around 1,228 pence, it is buying a claim on the portfolio at a discount using the trust's own cash, then deleting that underwater unit and lifting NAV per share for everyone who stays in. That is genuine value accretion, not a headline. It is also the point of the exercise: the board holds annual authority to buy back up to 14.99% of its shares at a discount to NAV, and its stated policy is to keep the discount in single digits.

The telling detail is the word "treasury." By parking repurchased shares in treasury rather than cancelling them, the board keeps the option to reissue them later, should the discount ever flip to a premium — shares that in the meantime carry no dividends and no votes. It is the posture of a manager who finds its own units a better buy than the rest of the catalogue, while refusing to give up the ability to sell them dear if sentiment turns.

Where does that leave a retail reader deciding whether to care? The evidence reading is mixed but coherent. On momentum, the trust is a top performer: for the year to end-October 2025 its NAV returned 30.2% and its share price 36.9%, against 26.4% for the benchmark and 17.9% for the Asia-Pacific peer average — first in its sector. The rebound tracks a rotation out of India into China plus heavy exposure to semiconductors and AI. On valuation, though, the current discount is wider than the trust's own five-year norm of 4.9%, so it is not dramatically cheap by its own history — it is a growth fund that got repriced down during the rising-rate years and is only now narrowing the gap.

The honest caveat is that none of these buybacks is large enough to move the needle alone. The recent purchases — 51,356 shares on 2 September, 13,464 on 28 August — sit against a market cap near £870 million. They add accretion and price support at the margin and, more usefully, they signal the board keeps acting while the discount stays wide.

The conclusion is a portfolio decision, not a forecast about the next quarter. If you want Asia-Pacific growth exposure and can sit through a concentrated, volatile growth sleeve, entering while the board itself is buying at a discount — roughly ten percent under NAV — is a cleaner entry than paying a premium later. The protection is not the buyback itself; it is the board's willingness to keep buying while the gap is wide, and the recent announcements show that cadence intact. What would break the case is a repeat of the rising-rate regime that punished growth strategies for two years and reopened the discount — the trade-off every growth holder accepts.